NeXtGen Biologics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

NeXtGen Biologics General Information

Description

Developer of extracellular matrix biomaterial products designed to harness axolotl-derived extracellular matrix components for tissue regeneration. The company offers a collagen wound matrix sourced from the axolotl's extracellular matrix to better manage complex conditions seen in general surgery, trauma, cardiovascular diseases, neurosurgery, orthopedics, and ophthalmology, enabling clinicians treating partial- and full-thickness wounds to support healing and improve the wound environment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 13200 Tech City Cir
  • Suite 100
  • Alachua, FL 32615
  • United States
+1 (800)
Primary Industry
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 13200 Tech City Cir
  • Suite 100
  • Alachua, FL 32615
  • United States
+1 (800)

NeXtGen Biologics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeXtGen Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Secondary Transaction - Private 01-Feb-2026 Completed Generating Revenue
8. Later Stage VC 22-Sep-2025 Completed Generating Revenue
7. Later Stage VC 01-Oct-2023 Completed Generating Revenue
6. Equity Crowdfunding 01-Mar-2023 Completed Generating Revenue
5. Later Stage VC 14-Aug-2020 Completed Generating Revenue
4. Debt - PPP 07-Apr-2020 Completed Generating Revenue
3. Accelerator/Incubator 06-Apr-2017 Completed Startup
2. Seed Round 03-Nov-2016 $1.5M $4.08M Completed Startup
1. Seed Round 30-Nov-2015 $2.58M $2.58M Completed Startup
To view NeXtGen Biologics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

NeXtGen Biologics Patents

NeXtGen Biologics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2943209-A1 Decellularized biomaterial form non-mammalian tissue Active 09-Jan-2013
EP-2943209-A4 Decellularized biomaterial form non-mammalian tissue Active 09-Jan-2013
EP-2943209-B1 Decellularized biomaterial form non-mammalian tissue Active 09-Jan-2013
EP-2943209-B8 Decellularized biomaterial form non-mammalian tissue Active 09-Jan-2013
CA-2897662-A1 Decellularized biomaterial from non-mammalian tissue Active 09-Jan-2013 A61L27/3687
To view NeXtGen Biologics’s complete patent history, request access »

NeXtGen Biologics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NeXtGen Biologics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Varia Ventures Venture Capital Minority
To view NeXtGen Biologics’s complete investors history, request access »

NeXtGen Biologics FAQs

  • When was NeXtGen Biologics founded?

    NeXtGen Biologics was founded in 2014.

  • Where is NeXtGen Biologics headquartered?

    NeXtGen Biologics is headquartered in Alachua, FL.

  • What is the size of NeXtGen Biologics?

    NeXtGen Biologics has 7 total employees.

  • What industry is NeXtGen Biologics in?

    NeXtGen Biologics’s primary industry is Other Devices and Supplies.

  • Is NeXtGen Biologics a private or public company?

    NeXtGen Biologics is a Private company.

  • What is NeXtGen Biologics’s current revenue?

    The current revenue for NeXtGen Biologics is .

  • How much funding has NeXtGen Biologics raised over time?

    NeXtGen Biologics has raised $6.7M.

  • Who are NeXtGen Biologics’s investors?

    Varia Ventures has invested in NeXtGen Biologics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process